Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Morphine Use in the ED and Outcomes of Patients With Acute Heart Failure, A Propensity Score-Matching Analysis Based on the EAHFE Registry

  • Miró, Oscar|||0000-0002-7924-9751
  • Gil, Víctor
  • Martín-Sánchez, Francisco Javier|||0000-0002-5970-725X
  • Herrero-Puente, Pablo|||0000-0002-5529-5008
  • Jacob, Javier|||0000-0003-1101-1066
  • Mebazaa, Alexandre|||0000-0001-8715-7753
  • Harjola, Veli-Pekka
  • Ríos, José|||0000-0002-0716-8784
  • Hollander, Judd E.
  • Peacock, W. Frank
  • Llorens Soriano, Pere|||0000-0002-9291-7179
Objective The objective was to determine the relationship between short-term mortality and intravenous morphine use in ED patients who received a diagnosis of acute heart failure (AHF). Methods Consecutive patients with AHF presenting to 34 Spanish EDs from 2011 to 2014 were eligible for inclusion. The subjects were divided into those with (M) or without IV morphine treatment (WOM) groups during ED stay. The primary outcome was 30-day all-cause mortality, and secondary outcomes were mortality at different intermediate time points, in-hospital mortality, and length of hospital stay. We generated a propensity score to match the M and WOM groups that were 1:1 according to 46 different epidemiological, baseline, clinical, and therapeutic factors. We investigated independent risk factors for 30-day mortality in patients receiving morphine. Results We included 6,516 patients (mean age, 81 [SD, 10] years; 56% women): 416 (6.4%) in the M and 6,100 (93.6%) in the WOM group. Overall, 635 (9.7%; M, 26.7%; WOM, 8.6%) died by day 30. After propensity score matching, 275 paired patients constituted each group. Patients receiving morphine had a higher 30-day mortality (55 [20.0%] vs 35 [12.7%] deaths; hazard ratio, 1.66; 95% CI, 1.09-2.54; P =.017). In patients receiving morphine, death was directly related to glycemia (P =.013) and inversely related to the baseline Barthel index and systolic BP (P =.021) at ED arrival (P =.021). Mortality was increased at every intermediate time point, although the greatest risk was at the shortest time (at 3 days: 22 [8.0%] vs 7 [2.5%] deaths; OR, 3.33; 95% CI, 1.40-7.93; P =.014). In-hospital mortality did not increase (39 [14.2%] vs 26 [9.1%] deaths; OR, 1.65; 95% CI, 0.97-2.82; P =.083) and LOS did not differ between groups (median [interquartile range] in M, 8 [7]; WOM, 8 [6]; P =.79). Conclusions This propensity score-matched analysis suggests that the use of IV morphine in AHF could be associated with increased 30-day mortality.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Tiempo de estancia prolongado en los pacientes ingresados por insuficiencia cardiaca aguda

  • Martín-Sánchez, F.J.
  • Carbajosa, V.
  • Llorens, P.
  • Herrero, P.
  • Jacob, J.
  • Miró, Ò.
  • Fernández, C.
  • Bueno, H.
  • Calvo, E.
  • Ribera Casado, J.M.
  • Adrada, E.R.
  • Lage, M.C.
  • Muñoz, M.
  • Coloma, E.
  • Gil, V.
  • Escoda, R.
  • Pérez-Durá, M.J.
  • Salvo, E.
  • Pavón, J.
  • álvarez, A.B.
  • Noval, A.
  • Torres, J.M.
  • López-Grima, M.L.
  • Valero, A.
  • Juan-Gómez, M.A.
  • Aguirre, A.
  • Pedragosa, M.A.
  • Alonso, M.I.
  • Sancho, H.
  • Ruiz, F.
  • Giménez, A.
  • Franco, J.M.
  • Pardo, S.
  • Mecina, A.B.
  • Rocío, Merino Genicio
  • Tost, J.
  • Penco, B.F.
  • Sánchez, A.L.
  • Fabregat, J.
  • Epelde, F.
  • Sánchez, S.
  • Piñera, P.
  • Garate, R.T.
  • Alquezar, A.
  • Rizzi, M.A.
  • Cabello, I.
  • Richard, F.
  • Lucas, J.
  • álvarez, J.V.
  • Morilla, A.A.
  • Irimia, A.
  • e, Isis Ba
  • Fuentes, M.
  • Gil, C.
Objetivo: Identificar los factores asociados al tiempo de estancia hospitalaria prolongado en pacientes ingresados/as por insuficiencia cardiaca aguda. Método: Estudio observacional de cohorte multipropósito que incluyó pacientes del registro EAHFE (Epidemiology Acute Heart Failure in Emergency) ingresados/as por insuficiencia cardiaca aguda en 25 hospitales españoles. Se recogieron variables demográficas y clínicas, el día y el lugar del ingreso. La variable resultado principal fue el tiempo de estancia hospitalaria mayor que la mediana. Resultados: Se incluyeron 2400 pacientes con una edad media de 79, 5 (±9, 9) años, de los cuales 1334 (55, 6%) eran mujeres. Quinientos noventa (24, 6%) ingresaron en la unidad de corta estancia (UCE), 606 (25, 2%) en cardiología y 1204 (50, 2%) en medicina interna o geriatría. La mediana del tiempo de estancia hospitalaria fue de 7, 0 (intervalo intercuartílico: 4-11 días). Cincuenta y ocho (2, 4%) pacientes fallecieron y 562 (23, 9%) sufrieron un reingreso a los 30 días tras el alta. Los factores independientes asociados a un tiempo de estancia hospitalaria prolongado fueron la enfermedad pulmonar obstructiva crónica, ser portador de un dispositivo, tener un factor precipitante desconocido o no común, la presencia en urgencias de insuficiencia renal, hiponatremia y anemia, no ingresar en una UCE o no disponer de dicha unidad e ingresar un lunes, martes o miércoles; y los asociados a un tiempo de estancia hospitalaria =7 días fueron la hipertensión arterial y tener como factor precipitante una crisis hipertensiva o la falta de adherencia al tratamiento. El área bajo la curva del modelo mixto ajustado al centro fue de 0, 78 (intervalo de confianza del 95%: 0, 76-0, 80; p <0, 001).Conclusiones: Hay una serie de factores asociados con un tiempo de estancia hospitalaria prolongado que deben ser considerados para la gestión del proceso de la insuficiencia cardiaca aguda. Objective: To identify the factors associated with prolonged length of hospital stay in patients admitted for acute heart failure. Methods: Multipurpose observational cohort study including patients from the EAHFE registry admitted for acute heart failure in 25 Spanish hospitals. Data were collected on demographic and clinical variables and on the day and place of admission. The primary outcome was length of hospital stay longer than the median. Results: We included 2, 400 patients with a mean age of 79.5 (9.9) years; of these, 1, 334 (55.6%) were women. Five hundred and ninety (24.6%) were admitted to the short stay unit (SSU), 606 (25.2%) to cardiology, and 1, 204 (50.2%) to internal medicine or gerontology. The mean length of hospital stay was 7.0 (RIC 4-11) days. Fifty-eight (2.4%) patients died and 562 (23.9%) were readmitted within 30 days after discharge. The factors associated with prolonged length of hospital stay were chronic pulmonary disease; being a device carrier; having an unknown or uncommon triggering factor; the presence of renal insufficiency, hyponatremia and anaemia in the emergency department; not being admitted to an SSU or the lack of this facility in the hospital; and being admitted on Monday, Tuesday or Wednesday. The factors associated with length of hospital stay=7days were hypertension, having a hypertensive episode, or a lack of treatment adherence. The area under the curve of the mixed model adjusted to the center was 0.78 (95% CI: 0.76-0.80; p < 0.001). Conclusions: A series of factors is associated with prolonged length of hospital stay and should be taken into account in the management of acute heart failure.